GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Tekla Healthcare Opportunities Fund (NYSE:THQ) » Definitions » 10-Year RORE %

THQ (Tekla Healthcare Opportunities Fund) 10-Year RORE % : 0.00% (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Tekla Healthcare Opportunities Fund 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Tekla Healthcare Opportunities Fund does not have enough data to calculate 10-Year RORE %.


Tekla Healthcare Opportunities Fund 10-Year RORE % Historical Data

The historical data trend for Tekla Healthcare Opportunities Fund's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tekla Healthcare Opportunities Fund 10-Year RORE % Chart

Tekla Healthcare Opportunities Fund Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
10-Year RORE %
Get a 7-Day Free Trial - - - - -

Tekla Healthcare Opportunities Fund Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tekla Healthcare Opportunities Fund's 10-Year RORE %

For the Asset Management subindustry, Tekla Healthcare Opportunities Fund's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tekla Healthcare Opportunities Fund's 10-Year RORE % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Tekla Healthcare Opportunities Fund's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Tekla Healthcare Opportunities Fund's 10-Year RORE % falls into.



Tekla Healthcare Opportunities Fund 10-Year RORE % Calculation

Tekla Healthcare Opportunities Fund's 10-Year RORE % for the quarter that ended in Sep. 2024 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( - )/( - )
=/
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2024 and 10-year before.


Tekla Healthcare Opportunities Fund  (NYSE:THQ) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Tekla Healthcare Opportunities Fund 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of Tekla Healthcare Opportunities Fund's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tekla Healthcare Opportunities Fund Business Description

Traded in Other Exchanges
N/A
Address
1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies in the healthcare industry (including equity securities, debt securities, and pooled investment vehicles). The fund invests in securities of public and private companies.
Executives
Rose Dimartino director C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103
Kathleen Goetz director 1310 OAK VALLEY CIRCLE, POLK CITY IA 50226
Bill Maher director 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101
Aberdeen Standard Investments Inc. other: Adviser 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103
Jaclyn Marie Matsick other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Marika Tooze other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Todd Reit director C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
James Joseph O'connor other: Director of Adviser C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Lucia Sitar officer: VP and Chief Legal Officer 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Christian Pittard officer: President ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH
Jennifer A Nichols other: Director of Adviser 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Stephen Bird director 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022
Joseph Andolina officer: Chief Compliance Officer & VP 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Alan R Goodson officer: Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Sharon Ferrari officer: Treasurer and CFO 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103

Tekla Healthcare Opportunities Fund Headlines

From GuruFocus

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 05-31-2023

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 02-28-2023

Tekla Healthcare Opportunities Fund Declares Monthly Cash Distribution

By Business Wire Business Wire 06-09-2023

Tekla Healthcare Opportunities Fund's Dividend Analysis

By GuruFocus Research 01-23-2024

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 08-31-2022

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 07-29-2022

Tekla Healthcare Opportunities Fund Declares Monthly Cash Distribution

By Business Wire Business Wire 08-10-2022

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 12-30-2022